• Proceedings of the Korean Institute of Navigation and Port Research Conference
• /
• 2012.10a
• /
• pp.365-367
• /
• 2012

해양교통시설 측정선 "한빛호"는 우리나라 전 해역의 광파표지(유 무인등대), 전파표지(GNSS, DGNSS, Loran-C 등), 음파표지(무신호기) 성능 측정 및 분석을 담당하는 국내 유일의 선박으로 그 중 전파표지의 GNSS와 DGNSS 측정된 수신테이터 분석을 통해 항법성능 요구조건 충족 여부와 전파 관련 유관기관에 참고자료로 활용하는데 기여하고자 합니다.

• Proceedings of the Korean Institute of Navigation and Port Research Conference
• /
• 2017.11a
• /
• pp.209-211
• /
• 2017

항로표지 음파표지로 사용되는 무신호기 주요 장비를 안정적인 성능이 담보되고 범용적으로 판매되는 제품을 선정함으로써 무신호기 고장발생 시 신속한 대처가 가능하도록 하고, 안개발생 방향을 고려하여 선택적으로 무신호기를 운영 할 수 있도록 설계하였다. 그리고 무신호기 음달거리를 공칭(명목적) 음달거리와 통상 음달거리에 대한 정확한 기준 없이 사용(표기)하는 등 통일성이 결여되어 공칭(명목적) 음달거리로 통일 할 필요성이 있다.

• Proceedings of the Korean Institute of Navigation and Port Research Conference
• /
• 2014.10a
• /
• pp.357-359
• /
• 2014

해상에서 선박의 안전한 항행을 위하여 항로표지를 운영하고 있으며, 항로표지는 형상표지, 광파표지, 음파표지, 전파표지, 특수신호표지로 구분할 수 있다. 전자기술의 발전과 안전한 항해에 도움을 주는 각종 시스템들이 등부표에 설치되고 있다. 이에 따라 등부표에서의 전력 수요는 과거보다 훨씬 더 많이 요구되고 있는 실정이다. 정부지원 연구과제로 등부표에서 태양광발전, 풍력발전 및 파력발전이 가능한 등부표용 발전시스템을 개발하였으며, 해상에 설치한 등부표에서 각종 에너지원으로 전력의 생산과 등부표 시스템의 운영에 따른 소비에 대한 분석이 필요하다. 현재 해상실험을 진행하고 있으며, TRS기반의 등부표용 통신시스템과 데이터 수신용 모니터링시스템을 설치하였고, 등부표내에서도 메모리카드를 이용하여 전력의 생산과 소비에 관련된 데이터 저장할 수 있게 구성하였다. TRS기반 모니터링시스템에서 저장된 데이터와 등부표에 설치한 메모리카드에 저장된 데이터 분석을 통하여 등부표용 하이브리드 발전시스템의 전력상태를 분석하였다.

• Proceedings of the Korean Institute of Navigation and Port Research Conference
• /
• 2010.10a
• /
• pp.23-24
• /
• 2010

오늘날 세계 각국은 글로벌 경제 체제에서 교역의 증대에 따라 해상 물동량이 증대되고 있으며 선박의 대형화, 고속화, 자동화, 또 해상대교나 신항만 건설 등 해상교통질서와 관련하여 항로표지 등 해양교통시설의 여건이 급격히 변화되었다. 이와 관련하여 항로표지는 항로의 혼잡을 방지하여 해운 물류를 원활히 하기 위한 수단이 된다. 항로표지는 광파, 형상, 음파, 전파 표지 등인데 이의 제도적 정비 및 규격의 표준화의 필요성과 방안을 분석하였다. 또한 국제표준과 한국표준의 제정 절차를 분석하고 국내용 항로표지용품 국토해양부 규격의 표준화 방안을 검토하였다. 향후, 항로표지의 기술적 분석, 항로 운영과 항로표지의 효율성, ICT 기술이 적용된 효과적 항로표지시스템분야에 있어서의 연구가 더욱 진행되어야 할 것이다.

• Journal of Digestive Cancer Research
• /
• v.5 no.1
• /
• pp.62-65
• /
• 2017

Pancreatic cancer is an aggressive disease and despite the efforts of the past few decades, the 5-year overall survival (OS) rate remains disappointing and does not exceed 10% in Korea. Especially, only 15-20% of patients are candidates for surgical resection because most patients are diagnosed with locally advanced or metastatic disease, and their only treatment approach is palliative chemotherapy. Since the first chemo-regimen of Gemcitabine and Nanoparticle albumin bound (nab) - paclitaxel was brought to clinical practice in 2013, the improvement in overall survival, progression-free survival, and response rate was achieved in patients with metastatic pancreatic adenocarcinoma. We report the case of a young patient with cardiogenic shock accompanied by multi-organ failure after 4^th cycle Gemcitabine and nab-paclitaxel chemotherapy with partial response.

• Journal of Chest Surgery
• /
• v.35 no.1
• /
• pp.27-35
• /
• 2002

Background: A perioperative myocardial infarction(PMI) is one of the major complications after CABG. Among diagnostic methods of PMI, CK-MB activity assays have been increasingly replaced by CK-MB mass assays, which have more sensitive, simple measurement. Also, new cardiac-specific and -sensitive marker, cardiac troponin I(cTnl), has been shown to be a marker of myocardial infarction. We report our evaluation of clinical significance of CK-MB mass and cTnl as a marker of PMI after CABG. Material and Method: We studied 32 patients who underwent CABG at Kangdong Sacred Hospital between April 2000 and April 2001. Postoperative serum CK-MB activity level, serum CK-MB mass, cTnl, electrocardiogram, echocardiogram, and clinical data were recorded prospectively The diagnosis of PMI was defined as positive 2 among 3 or all of the following , by a new Q wave on the electrocardiogram, by serum CK-MB activity higher than 200 lU/L within 72 hours after operation, and by new regional wall motion abnormality on the echocardiogram. Result: After CABG, 3 patients had sustained a PMI according to current diagnostic criteria. As serum CK-MB activity time course, a level of CK-MB activity 12 hours after CABG had very linear correlated significance with serum CK-MB mass 24hours(R=0.946) and cTnl 48 hours(R=0.933) after CABG(p=0.000). As we used a receiver operating characteristics curve(ROC curve) for a diagnostic cutoff value in patients with PMI, serum CK-MB mass levels higher than 30.05 ug/L 24 hours after CABG detected the presence of PMI with an area under the ROC curve of 1.0, a sensitivity of 100%, a specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 100%. Also serum cTnl levels higher than 17.15 ug/L 48 hours after CABG detected the presence of PMI with an area under the ROC curve of 0.98, a sensitivity of 100%, a specificity of 96.6%, a positive preclictive value of 75%, and a negative predictive value of 100% Conclusion: We concluded that both the measurement of CK-MB mass and cTnl are the easier, accurate methods as a diagnostic marker of PMT after CABG, also as a proposal of diagnostic cutoff value enables to an early detection of PMI. However, a 1arger number of patient will be needed because of statistic limitation that a small number of participating patients, a small number of PMI.

• The Korean Journal of Nuclear Medicine Technology
• /
• v.19 no.1
• /
• pp.57-61
• /
• 2015

Purpose We considered the correlation of Ejection Fraction (EF) which was analyzed by Multi Gated Blood Pool Scan (MUGA) and Echocardiography (ECHO) for the patients who were classified according to the condition of cardiac function. Materials and Methods We analyzed the patients (female 60) who were diagnosed with breast cancer and were examined by both MUGA and ECHO. The 30 patients (age: $58.27{\pm}13.48$) who were analyzed into less than 50% to 70% of EF were categorized as normal group and the other 30 patients (age: $53.70{\pm}8.45$) who were analyzed into less than 50% of EF were categorized as abnormal group. Statistical analysis with SPSS ver. 18 was applied. Results Each of the value of mean and standard deviation of normal group was $66.43{\pm}5.80$ (MUGA), $60.50{\pm}4.93$ (ECHO). There was a significant difference (p<0.001). Each of the value of mean and standard deviation of abnormal group was $41.93{\pm}7.58$ (MUGA), $41.70{\pm}11.49$ (ECHO). There was no significant difference (p>0.001). In the result, all 30 cases of normal group showed the same reading. 8 out of 30 cases in abnormal group showed inconsistency of the reading. Conclusion We could confirm the correlation of the EF in MUGA and ECHO statistically. There was difference between abnormal groups from the result of reading. If we are aware of the result according to the different cardiac function categorization, MUGA and ECHO can be used as even more accurate interchangeable test.